Proactive Investors - Run By Investors For Investors

Small-Cap Snapshot: ADMA Biologics shares rise after FDA accepts its drug application amendment

The biotech acquired the drug Bivigam in an acquisition but production stopped while the facility was renovated
Scientist in a lab
Bivigam is a treatment for immune system disorders

Supervalu Inc (NYSE:SVU) is a top gainer following a US$2.9bn buyout deal from United Natural Foods Inc (NASDAQ:UNFI). The grocery retailer is the primary supplier of Amazon.com Inc’s Whole Foods. Shareholders will receive US$32.50 per share in cash. Shares of the Minnesota-based company were up nearly 65% to US$32.02 in Thursday morning trading.

ADMA Biologics Inc (NASDAQ:ADMA) shares are up following the announcement that the US Food and Drug Administration accepted its amendment to its drug application. The biotech acquired the drug Bivigam, a treatment for immune disorders, in an acquisition. Production stopped while the facility was shut down and renovated. Shares of the New Jersey-based company were up more than 18% to US$5.86.

Genprex Inc (NASDAQ:GNPX) inked a deal with the University of Texas MD Anderson Cancer Center. The pair will work together on a study of its drug Oncoprex, administering it alongside immunotherapies. The clinical-stage gene therapy company will pay the university center US$2mln to conduct the study. Shares of the company were down around 1.5% to US$6.99.

READ: Small-Cap Snapshot: Medical device company Nevro is on the rise after a court rules in its favor

MoSys Inc (NASDAQ:MOSY) was a top decliner after announcing it would soon lose a major customer. The semiconductor company reported earnings of US$0.06 per share compared with an earnings loss of US$0.42 in its previous second quarter. However, news that an unnamed customer would be phasing out its products in the next 24 months offset the positive results. Shares fell more than 40% to US$1.21.

LSB Industries Inc (NYSE:LXU) shares sank as downtime at the chemical maker’s factories weighed on its second-quarter results. The company reported a net loss of US$27.5mln compared with a loss of US$7mln in its previous second quarter. Its El Dorado ammonia facility in Arkansas was out of service after a power outage caused tube failures. Shares of the Oklahoma-based company were down more than 15% to US$6.53.

The Russell 2000 small-cap index was up slightly in Thursday afternoon trading.

View full MOSY profile View Profile

MoSys Timeline

Related Articles

Platinum
January 04 2019
In its outlook for 2019, the firm said the focus was now “not only on continuous improvements in feed grade and recoveries but on expanding the business into new jurisdictions”
Kazakhstan
November 20 2018
Borko Moric will succeed Parilla as chief executive officer. Bojan Moric will become the company's chief operations officer
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use